It is unclear how to optimally care for chronic kidney disease (CKD). This study compares a new coordinated model to usual care for CKD.
A randomized trial in nephrology clinics and the community included 474 patients with median estimated GFR (eGFR) 42 ml/min per 1.73 m(2) identified by laboratory-based case finding compared care coordinated by a general practitioner (controls) with care by a nurse-coordinated team including a nephrologist (intervention) for a median (interquartile range [IQR]) of 742 days. 32% were diabetic, 60% had cardiovascular disease, and proteinuria was minimal. Guided by protocols, the intervention team targeted risk factors for adverse kidney and cardiovascular outcomes. Serial eGFR and clinical events were tracked.
The average decline in eGFR over 20 months was -1.9 ml/min per 1.73 m(2). eGFR declined by =4 ml/min per 1.73 m(2) within 20 months in 28 (17%) intervention patients versus 23 (13.9%) control patients. Control of BP, LDL, and diabetes were comparable across groups. In the intervention group there was a trend to greater use of renin-angiotensin blockers and more use of statins in those with initial LDL >2.5 mmol/L. Treatment was rarely required for anemia, acidosis, or disordered mineral metabolism. Clinical events occurred in 5.2% per year.
Patients with stage 3/4 CKD identified through community laboratories largely had nonprogressive kidney disease but had cardiovascular risk. Over a median of 24 months, the nurse-coordinated team did not affect rate of GFR decline or control of most risk factors compared with usual care.
Notes
Cites: Am J Kidney Dis. 2001 Mar;37(3):484-911228171
Cites: Ann Intern Med. 2001 Apr 17;134(8):629-3611304102
Cites: J Am Soc Nephrol. 2001 Aug;12(8):1713-2011461944
Cites: Ann Med. 2001 Jul;33(5):375-8411491197
Cites: N Engl J Med. 2001 Sep 20;345(12):851-6011565517
Cites: Arch Intern Med. 2004 Mar 22;164(6):659-6315037495
Cites: Am J Kidney Dis. 2004 May;43(5):825-3515112173
Cites: Am J Kidney Dis. 2004 Oct;44(4):706-1415384022